Below are the most recent publications written about "Antibodies, Protozoan" by people in Profiles.
-
Kayatani AKK, Bobbili N, Megnekou R, Matsunaga M, Leke RFG, Taylor DW. Are high avidity antibodies to Plasmodium falciparum antigens preferentially transferred across the placenta of premature and term babies? Placenta. 2023 09 07; 140:11-19.
-
Tassi Yunga S, Siriwardhana C, Fouda GG, Bobbili N, Sama G, Chen JJ, Leke RFG, Taylor DW. Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area. Malar J. 2022 Nov 19; 21(1):346.
-
Kayatani AKK, Leke RGF, Leke RIJ, Fogako J, Taylor DW. Transplacental transfer of total immunoglobulin G and antibodies to Plasmodium falciparum antigens between the 24th week of gestation and term. Sci Rep. 2022 11 07; 12(1):18864.
-
Oliveira-da-Silva JA, Machado AS, Ramos FF, Tavares GSV, Lage DP, Mendon?a DVC, Pereira IAG, Santos TTO, Martins VT, Carvalho LM, Freitas CS, Ludolf F, Reis TAR, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Roatt BM, Teixeira AL, Coelho EAF. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis. Cell Immunol. 2020 10; 356:104194.
-
Oliveira-da-Silva JA, Lage DP, Ramos FF, Machado AS, Tavares GSV, Mendon?a DVC, Pereira IAG, Martins VT, Carvalho LM, Ludolf F, Santos TTO, Reis TAR, Oliveira CS, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Menezes-Souza D, Roatt BM, Teixeira AL, Coelho EAF. Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis. Mol Immunol. 2020 08; 124:161-171.
-
Taylor DW, Bobbili N, Kayatani A, Tassi Yunga S, Kidima W, Leke RFG. Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach. Malar J. 2020 May 01; 19(1):171.
-
Spinicci M, Gabrielli S, Rojo D, Gamboa H, Macchioni F, Mantella A, Lara Y, Villagr?n AL, Roselli M, Strohmeyer M, Cinelli C, Corti G, Bartalesi F, Vargas R, Vedia A, Castellanos P, Monasterio J, Cancrini G, Bartoloni A. Trypanosoma cruzi infection in the human population of the Bolivian Chaco: four serosurveys over a 26-year period (1987-2013). J Infect Dev Ctries. 2020 02 29; 14(2):199-206.
-
Lage DP, Machado AS, Ramos FF, Silveira PC, Dias DS, Ribeiro PAF, Tavares GSV, Costa LE, Santos TTO, Steiner BT, Fagundes MI, Ch?vez-Fumagalli MA, Lyon S, Moreira RLF, Duarte MC, Menezes-Souza D, Caligiorne RB, Machado-de-?vila RA, Teixeira AL, Coelho EAF. A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein. Immunobiology. 2019 07; 224(4):477-484.
-
Ribeiro PAF, Dias DS, Lage DP, Martins VT, Costa LE, Santos TTO, Ramos FF, Tavares GSV, Mendon?a DVC, Ludolf F, Gomes DA, Rodrigues MA, Ch?vez-Fumagalli MA, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF. Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection. Mol Immunol. 2019 02; 106:108-118.
-
Lloyd YM, Fang R, Bobbili N, Vanda K, Ngati E, Sanchez-Quintero MJ, Salanti A, Chen JJ, Leke RGF, Taylor DW. Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaound?, Cameroon. Infect Immun. 2018 09; 86(9).